Recombinant human LTA/TNF-beta protein

Cat No.
ATGP3420

Size

QTY

List Price

10ug

USD 130


20ug

USD 240

50ug

USD 320

100ug

USD 530

250ug

USD 930

500ug

USD 1,590

1mg

USD 2,650

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
Baculovirus
Domain
35-205aa
UniProt No.
P01374
NCBI Accession No.
NP_001153212
Alternative names
Lymphotoxin-alpha, LT-alpha, TNF-beta, Tumor necrosis factor ligand superfamily member 1, TNFB, TNFSF1, TNF superfamily, member 1

Product Specification

Molecular Weight
19.7 kDa (180aa)
Concentration
0.5mg/ml (determined by absorbance at 280nm)
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
Purity
> 90% by SDS-PAGE
Bioactivity
Measured in a cytotoxicity assay using L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. The ED50 range ≤ 1ng/ml.
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
His-Tag
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain.

Biological Activity

Human LTA/TNF-beta induces cell cytotoxicity in the L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.